China's Xiidra Challenger VivaVision Biotech Carries Out Series C
2020-05-27 15:46:26
VivaVision Biotech undertook its Series C funding round, hoping to create a blockbuster drug for the treatment of ‘dry eye syndrome.
--By Fan Zhang ( EqualOcean )
View details